Patrick Yéni

13.1k total citations · 7 hit papers
89 papers, 8.5k citations indexed

About

Patrick Yéni is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Patrick Yéni has authored 89 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Infectious Diseases, 56 papers in Virology and 22 papers in Epidemiology. Recurrent topics in Patrick Yéni's work include HIV/AIDS drug development and treatment (58 papers), HIV Research and Treatment (55 papers) and HIV/AIDS Research and Interventions (47 papers). Patrick Yéni is often cited by papers focused on HIV/AIDS drug development and treatment (58 papers), HIV Research and Treatment (55 papers) and HIV/AIDS Research and Interventions (47 papers). Patrick Yéni collaborates with scholars based in France, United States and United Kingdom. Patrick Yéni's co-authors include Donna M. Jacobsen, Douglas D. Richman, Scott M. Hammer, Martin Hirsch, Robert T. Schooley, Melanie Thompson, Paul A. Volberding, Margaret A. Fischl, José M. Gatell and Joan Montaner and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Patrick Yéni

88 papers receiving 8.1k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Antiretroviral Therapy in Adults

2000 874 citations Charles C. J. Carpenter, Margaret A. Fischl et al. JAMA profile →
Antiretroviral Therapy for HIV Infection in 1998

1998 837 citations Charles C. J. Carpenter, Margaret A. Fischl et al. JAMA profile →
Antiretroviral Treatment of Adult HIV Infection

2008 832 citations Scott M. Hammer, Robert T. Schooley et al. JAMA profile →
Treatment for Adult HIV Infection

2006 767 citations Scott M. Hammer, Michael S. Saag et al. JAMA profile →
Treatment for Adult HIV Infection

2004 601 citations Patrick Yéni, Scott M. Hammer et al. JAMA profile →
Antiretroviral Treatment of Adult HIV Infection

2010 595 citations Melanie Thompson, Joan Montaner et al. JAMA profile →
Antiretroviral Treatment for Adult HIV Infection in 2002

2002 573 citations Patrick Yéni, Scott M. Hammer et al. JAMA profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick Yéni France	31	6.8k	5.3k	2.1k	1.7k	519	89	8.5k
David A. Cooper Australia	39	5.5k 0.8×	4.4k 0.8×	1.6k 0.8×	1.4k 0.9×	633 1.2×	118	7.1k
Roy M. Gulick United States	50	8.3k 1.2×	6.7k 1.3×	1.9k 0.9×	1.6k 1.0×	526 1.0×	168	10.6k
Jack Fuhrer United States	19	6.2k 0.9×	4.2k 0.8×	3.4k 1.6×	2.5k 1.5×	534 1.0×	33	9.3k
Courtney V. Fletcher United States	48	5.5k 0.8×	4.2k 0.8×	2.1k 1.0×	1.3k 0.8×	489 0.9×	230	8.4k
Richard Haubrich United States	47	6.5k 1.0×	4.9k 0.9×	2.2k 1.1×	1.6k 1.0×	444 0.9×	184	8.8k
Anton Pozniak United Kingdom	53	8.2k 1.2×	5.2k 1.0×	3.5k 1.7×	1.9k 1.1×	747 1.4×	294	10.7k
Keith Henry United States	49	4.4k 0.6×	3.9k 0.7×	1.9k 0.9×	1.4k 0.9×	263 0.5×	135	7.2k
Valériane Leroy France	48	5.3k 0.8×	2.1k 0.4×	2.9k 1.4×	1.2k 0.7×	374 0.7×	283	7.8k
Alexandra Calmy Switzerland	53	6.5k 0.9×	3.8k 0.7×	3.2k 1.5×	3.3k 2.0×	801 1.5×	305	10.1k
Judith Feinberg United States	43	5.0k 0.7×	3.3k 0.6×	3.2k 1.5×	1.2k 0.7×	423 0.8×	169	8.0k

Countries citing papers authored by Patrick Yéni

Since Specialization

Citations

This map shows the geographic impact of Patrick Yéni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Yéni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Yéni more than expected).

Fields of papers citing papers by Patrick Yéni

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick Yéni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Yéni. The network helps show where Patrick Yéni may publish in the future.

Co-authorship network of co-authors of Patrick Yéni

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick Yéni. A scholar is included among the top collaborators of Patrick Yéni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick Yéni. Patrick Yéni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sénard, Olivia, Charles Burdet, Benoît Visseaux, et al.. (2016). Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study. AIDS Research and Human Retroviruses. 33(1). 11–16. 4 indexed citations

Charpentier, Charlotte, Minh Lê, Véronique Joly, et al.. (2015). Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up. PLoS ONE. 10(7). e0134430–e0134430. 3 indexed citations

Piroth, Lionel, Laëtitia Moinot, Patrick Yéni, et al.. (2015). Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial). Journal of Antimicrobial Chemotherapy. 71(2). 490–496. 4 indexed citations

Krastinova, Evguenia, Rémonie Seng, Patrick Yéni, et al.. (2013). Is Clinical Practice Concordant with the Changes in Guidelines for Antiretroviral Therapy Initiation during Primary and Chronic HIV-1 Infection? The ANRS PRIMO and COPANA Cohorts. PLoS ONE. 8(8). e71473–e71473. 12 indexed citations

Yéni, Patrick, Anthony Mills, Monika Peeters, et al.. (2010). Etravirine in the Treatment of HIV-1: A Clinical Overview for Healthcare Professionals. Current HIV Research. 8(7). 564–576. 2 indexed citations

Joly, Véronique, et al.. (2010). Silicone in HIV-1-infected patients: a cause of misdiagnosed granulomatous disease. International Journal of Infectious Diseases. 14. e277–e279. 6 indexed citations

Joly, Véronique, Kaoutar Jidar, Mercedes Tatay, & Patrick Yéni. (2010). Enfuvirtide: from basic investigations to current clinical use. Expert Opinion on Pharmacotherapy. 11(16). 2701–2713. 31 indexed citations

Landman, Roland, et al.. (2009). Immunovirological and therapeutic follow-up of HIV-1/HIV-2-dually seropositive patients. AIDS. 23(3). 426–428. 12 indexed citations

Hirsch, Martin S., Huldrych F. Günthard, Jonathan Schapiro, et al.. (2008). Antiretroviral Drug Resistance Testing in Adult HIV‐1 Infection: 2008 Recommendations of an International AIDS Society–USA Panel. Clinical Infectious Diseases. 47(2). 266–285. 375 indexed citations

10.

Sitbon, Olivier, Caroline Lascoux‐Combe, Jean‐François Delfraissy, et al.. (2007). Prevalence of HIV-Related Pulmonary Arterial Hypertension in the Current Antiretroviral Therapy Era. American Journal of Respiratory and Critical Care Medicine. 177(1). 108–113. 322 indexed citations

11.

Hammer, Scott M., Michael S. Saag, Mauro Schechter, et al.. (2006). Treatment for Adult HIV Infection. JAMA. 296(7). 827–827. 767 indexed citations breakdown →

12.

Eron, Joseph J., Patrick Yéni, Joseph Gathe, et al.. (2006). The KLEAN study of fosamprenavir-ritonavir versus lopinavir-ritonavir, each in combination with abacavir-lamivudine, for initial treatment of HIV infection over 48 weeks: a randomised non-inferiority trial. The Lancet. 368(9534). 476–482. 258 indexed citations

13.

Abgrall, Sophie, Patrick Yéni, Olivier Bouchaud, & Dominique Costagliola. (2006). Switch from a first virologically effective protease inhibitor-containing regimen to a regimen containing efavirenz, nevirapine or abacavir. AIDS. 20(16). 2099–2106. 8 indexed citations

14.

Morand‐Joubert, Laurence, Fabienne Marcellin, Odile Launay, et al.. (2005). Contribution of cellular HIV-1 DNA quantification to the efficacy analysis of antiretroviral therapy: a randomized comparison of 2 regimens, including 3 drugs from 2 or 3 classes (TRIANON, ANRS 081).. PubMed. 38(3). 268–76. 16 indexed citations

15.

Descamps, Diane, Véronique Joly, Philippe Flandre, et al.. (2004). Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073). Journal of Clinical Virology. 33(2). 99–103. 4 indexed citations

16.

Charreau, Isabelle, et al.. (2001). Adverse Reactions to Cotrimoxazole in HIV-infected Patients: Predictive Factors and Subsequent HIV Disease Progression. Scandinavian Journal of Infectious Diseases. 33(10). 759–764. 19 indexed citations

17.

Couvelard, Anne, et al.. (1999). Nodular Lesions of the Liver Revealing Multiple Myeloma. Leukemia & lymphoma. 33(3-4). 389–392. 15 indexed citations

18.

Bolard, Jacques, Véronique Joly, & Patrick Yéni. (1997). Amphotéricine B : ancien médicament, nouveaux concepts. 3(3). 207–213. 2 indexed citations

19.

Yéni, Patrick, et al.. (1997). Evaluation of Renal Acidification in HIV-lnfected Patients with Hypergammaglobulinemia. Nephron. 75(2). 196–200. 1 indexed citations

20.

Olivier, Catherine, et al.. (1993). Diagnosis of Primary Tuberculosis in Children by Amplification and Detection of Mycobacterial DNA. American Review of Respiratory Disease. 147(2). 420–424. 61 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact